Follow
Avanish Kumar Pandey
Avanish Kumar Pandey
All India Institute of Medical Sciences, New Delhi, India
Verified email at aiims.edu - Homepage
Title
Cited by
Cited by
Year
Elucidations of molecular mechanism and mechanistic effects of environmental toxicants in neurological disorders
H Goel, K Goyal, AK Pandey, M Benjamin, F Khan, P Pandey, S Mittan, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2023
192023
Unravelling the molecular mechanism of mutagenic factors impacting human health
K Goyal, H Goel, P Baranwal, A Dixit, F Khan, NK Jha, KK Kesari, ...
Environmental science and pollution research 29 (41), 61993-62013, 2022
172022
Immunological mechanisms of vaccine-induced protection against SARS-CoV-2 in humans
K Goyal, H Goel, P Baranwal, A Tewary, A Dixit, AK Pandey, M Benjamin, ...
Immuno 1 (4), 442-456, 2021
132021
Prognostic relevance of NPM1, CEBPA, and FLT3 mutations in cytogenetically normal adult AML patients
A Ningombam, D Verma, R Kumar, J Singh, MS Ali, AK Pandey, I Singh, ...
American Journal of Blood Research 13 (1), 28, 2023
102023
Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia
S Kumari, MS Ali, J Singh, M Arora, D Verma, AK Pandey, M Benjamin, ...
Hematological Oncology 40 (4), 577-587, 2022
52022
Prognostic relevance of surface expression of cytokine receptor-like factor 2 in pediatric B-lineage acute lymphoblastic leukemia
J Singh, M Benjamin, AK Pandey, S Kumari, MS Ali, JK Palanichamy, ...
American Journal of Cancer Research 13 (6), 2452, 2023
42023
Copy number alterations in CDKN2A/2B and MTAP genes are associated with low MEF2C expression in T-cell acute lymphoblastic leukemia
S Kumari, J Singh, M Arora, MS Ali, AK Pandey, M Benjamin, ...
Cureus 14 (12), 2022
42022
Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 Expression
A Ningombam, D Verma, R Kumar, J Singh, MS Ali, AK Pandey, I Singh, ...
Asian Pacific Journal of Cancer Prevention: APJCP 25 (7), 2283, 2024
2024
POSTER: ALL-352 Exploring DUX4-Rearranged B-ALL in India: Incidence, Molecular Pathways, and Potential Biomarkers
M Benjamin, J Singh, AK Pandey, N Thukral, S Kumari, S Bakhshi, ...
Clinical Lymphoma Myeloma and Leukemia 23, S151, 2023
2023
ALL-352 Exploring DUX4-Rearranged B-ALL in India: Incidence, Molecular Pathways, and Potential Biomarkers
M Benjamin, J Singh, AK Pandey, N Thukral, S Kumari, S Bakhshi, ...
Clinical Lymphoma Myeloma and Leukemia 23, S248-S249, 2023
2023
P335: PROGNOSTIC UTILITY OF NON-HOMOLOGOUS END JOINING DNA REPAIR PATHWAY GENES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
A Chopra, S Kumari, M Arora, A Pandey, N Thukral, M Benjamin, J Singh, ...
HemaSphere 7 (S3), e31720ad, 2023
2023
P326: PROGNOSTIC UTILITY OF NON-HOMOLOGOUS END JOINING DNA REPAIR PATHWAY GENES IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
S KUMARI, J SINGH, M Arora, S Bakhshi, JK Palanichamy, A Sharma, ...
HemaSphere 6, 226-227, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–12